Advanced search
Publication Cover
Future Virology Volume 3, 2008 - Issue 2
Submit an article Journal homepage
113
Views
0
CrossRef citations to date
0
Altmetric
Review

The Influenza Matrix Protein 2 as a Vaccine Target

Xavier SaelensDepartment for Molecular Biomedical Research, VIB, Ghent, Belgium, and, Department for Molecular Biology, Ghent University, Ghent Technologiepark 927, B-9052Ghent, Belgium. Tel.: +32 9 33 13 620; Fax: +.32 9 33 13 609; [email protected]View further author information
Pages 167-178 | Published online: 29 Feb 2008

Bibliography

  • Wood JM , RobertsonJS: Reference viruses for seasonal and pandemic influenza vaccine preparation.Influenza Other Respir. Viruses1(1) , 5–9 (2007).
  • Min Jou W , VerhoeyenM, DevosR et al.: Complete structure of the hemagglutinin gene from the human influenza a/victoria/3/75 (H3N2) strain as determined from cloned DNA. Cell19(3) , 683–696 (1980).
  • Russell CJ , WebsterRG: The genesis of a pandemic influenza virus.Cell123(3) , 368–371 (2005).
  • Verhoeyen M , FangR, JouWM et al.: Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/aichi/2/68 and A/victoria/3/75. Nature286(5775) , 771–776 (1980).
  • Smith DJ , LapedesAS, de Jong JC et al.: Mapping the antigenic and genetic evolution of influenza virus. Science305(5682) , 371–376 (2004).
  • Treanor JD : Influenza – the goal of control.N. Engl. J. Med.357(14) , 1439–1441 (2007).
  • Nichol KL , TreanorJJ: Vaccines for seasonal and pandemic influenza.J. Infect. Dis.194(Suppl.) , 2S111–2S118 (2006).
  • Jefferson T , RivettiD, RivettiA et al.: Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet366(9492) , 1165–1174 (2005).
  • Jefferson T : Influenza vaccination: policy versus evidence.Br. Med. J.333(7574) , 912–915 (2006).
  • Nicholson KG , WoodJM, ZambonM: Influenza.Lancet362(9397) , 1733–1745 (2003).
  • Fouchier RA , MunsterV, WallenstenA et al.: Characterization of a novel Influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol.79(5) , 2814–2822 (2005).
  • Guan Y , PoonLL, CheungCY et al.: H5N1 influenza: a protean pandemic threat. Proc. Natl Acad. Sci. USA101(21) , 8156–8161 (2004).
  • Fang R , Min Jou W, Huylebroeck D et al.: Complete structure of A/duck/ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell25(2) , 315–323 (1981).
  • Gething MJ , ByeJ, SkehelJ et al.: Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature287(5780) , 301–306 (1980).
  • Scholtissek C , RohdeW, Von Hoyningen V et al.: On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology87(1) , 13–20 (1978).
  • Taubenberger JK , ReidAH, LourensRM et al.: Characterization of the 1918 influenza virus polymerase genes. Nature437(7060) , 889–893 (2005).
  • Leroux-Roels I , BorkowskiA, VanwolleghemT et al.: Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet370(9587) , 580–589 (2007).
  • Gerhard W , MozdzanowskaK, ZharikovaD: Prospects for universal influenza virus vaccine.Emerg. Infect. Dis.12(4) , 569–574 (2006).
  • Sakaguchi T , TuQ, PintoLH et al.: The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc. Natl Acad. Sci. USA94(10) , 5000–5005 (1997).
  • Venkataraman P , LambRA, PintoLH: Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of Influenza A virus.J. Biol. Chem.280(22) , 21463–21472 (2005).
  • Lamb RA , ZebedeeSL, RichardsonCD: Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.Cell40(3) , 627–633 (1985).
  • Takeuchi K , LambRA: Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.J. Virol.68(2) , 911–919 (1994).
  • Takeuchi K , ShaughnessyMA, LambRA: Influenza virus M2 protein ion channel activity is not required to maintain the equine-1 hemagglutinin in its native form in infected cells.Virology202(2) , 1007–1011 (1994).
  • Ciampor F , BayleyPM, NermutMV et al.: Evidence that the amantadine-induced, M2-mediated conversion of Influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology188(1) , 14–24 (1992).
  • Ohuchi M , CramerA, VeyM et al.: R escue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J. Virol.68(2) , 920–926 (1994).
  • Wang C , TakeuchiK, PintoLH et al.: Ion channel activity of Influenza A virus M2 protein: characterization of the amantadine block. J. Virol.67(9) , 5585–5594 (1993).
  • Simonsen L , ViboudC, GrenfellBT et al.: The genesis and spread of reassortment human Influenza A/H3N2 viruses conferring adamantane resistance. Mol. Biol. Evol.24(8) , 1811–1820 (2007).
  • Bright RA , MedinaMJ, XuX et al.: Incidence of adamantane resistance among Influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet366(9492) , 1175–1181 (2005).
  • Tobler K , KellyML, PintoLH et al.: Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of Influenza A virus. J. Virol.73(12) , 9695–9701 (1999).
  • McCown MF , PekoszA: The Influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging.J. Virol.79(6) , 3595–3605 (2005).
  • Iwatsuki-Horimoto K , HorimotoT, NodaT et al.: The cytoplasmic tail of the Influenza A virus M2 protein plays a role in viral assembly. J. Virol.80(11) , 5233–5240 (2006).
  • Sharp PM : Origins of human virus diversity.Cell108(3) , 305–312 (2002).
  • Black RA , RotaPA, GorodkovaN et al.: Antibody response to the M2 protein of Influenza A virus expressed in insect cells. J. Gen. Virol.74(Pt 1) , 143–146 (1993).
  • Feng J , ZhangM, MozdzanowskaK et al.: Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J.3 , 102 (2006).
  • Kitikoon P , StraitEL, ThackerEL: The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.Vet. Microbiol.126(1-3) , 51–62 (2007).
  • Liu W , LiH, ChenYH: N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.FEMS Immunol. Med. Microbiol.35(2) , 141–146 (2003).
  • Mozdzanowska K , FengJ, EidM et al.: Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine21(19–20) , 2616–2626 (2003).
  • Bui HH , PetersB, AssarssonE et al.: Ab and T cell epitopes of Influenza A virus, knowledge and opportunities. Proc. Natl Acad. Sci. USA104(1) , 246–251 (2007).
  • Jameson J , CruzJ, EnnisFA: Human cytotoxic T-lymphocyte repertoire to Influenza A viruses.J. Virol.72(11) , 8682–8689 (1998).
  • Jameson J , CruzJ, TerajimaM et al.: Human CC8+ and CD4+ T lymphocyte memory to Influenza A viruses of swine and avian species. J. Immunol.162(12) , 7578–7583 (1999).
  • Park EK , CastrucciMR, PortnerA et al.: The M2 ectodomain is important for its incorporation into Influenza A virions. J. Virol.72(3) , 2449–2455 (1998).
  • Kovacova A , Ruttkay-NedeckyG, Haverlik IK et al.: Sequence similarities and evolutionary relationships of influenza virus A hemagglutinins. Virus Genes24(1) , 57–63 (2002).
  • Zebedee SL , LambRA: Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.J. Virol.62(8) , 2762–2772 (1988).
  • Hughey PG , RobertsPC, HolsingerLJ et al.: Effects of antibody to the Influenza A virus M2 protein on M2 surface expression and virus assembly. Virology212(2) , 411–421 (1995).
  • Treanor JJ , TierneyEL, ZebedeeSL et al.: Passively transferred monoclonal antibody to the M2 protein inhibits Influenza A virus replication in mice. J. Virol.64(3) , 1375–1377 (1990).
  • Slepushkin VA , KatzJM, BlackRA et al.: Protection of mice against Influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine13(15) , 1399–1402 (1995).
  • Neirynck S , DerooT, SaelensX et al.: A universal Influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med.5(10) , 1157–1163 (1999).
  • Noad R , RoyP: Virus-like particles as immunogens.Trends Microbiol.11(9) , 438–444 (2003).
  • De Filette M , Min Jou W, Birkett A et al.: Universal Influenza A vaccine: optimization of M2-based constructs. Virology337(1) , 149–161 (2005).
  • Eriksson AM , SchonKM, LyckeNY: The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues.J. Immunol.173(5) , 3310–3319 (2004).
  • De Filette M , FiersW, MartensW et al.: Improved design and intranasal delivery of an M2e-based human Influenza A vaccine. Vaccine24(44–46) , 6597–6601 (2006).
  • De Filette M , RamneA, BirkettA et al.: The universal influenza vaccine M2e–HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine24(5) , 544–551 (2006).
  • Frace AM , KlimovAI, RoweT et al.: Modified M2 proteins produce heterotypic immunity against Influenza A virus. Vaccine17(18) , 2237–2244 (1999).
  • Jegerlehner A , TissotA, LechnerF et al.: A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine20(25–26) , 3104–3112 (2002).
  • Liu W , PengZ, LiuZ et al.: High epitope density in a single recombinant protein molecule of the extracellular domain of Influenza A virus M2 protein significantly enhances protective immunity. Vaccine23(3) , 366–371 (2004).
  • Ernst WA , KimHJ, TumpeyTM et al.: Protection against H1, H5, H6 and H9 Influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine24(24) , 5158–5168 (2006).
  • Fan J , LiangX, HortonMS et al.: Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine22(23–24) , 2993–3003 (2004).
  • Tompkins SM , ZhaoZS, LoCY et al.: Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. Infect. Dis.13(3) , 426–435 (2007).
  • Brown EG , LiuH, KitLC et al.: Pattern of mutation in the genome of Influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl Acad. Sci. USA98(12) , 6883–6888 (2001).
  • Heinen PP , RijsewijkFA, de Boer-Luijtze EA et al.: Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with Influenza A virus. J. Gen. Virol.83(Pt 8) , 1851–1859 (2002).
  • Jegerlehner A , SchmitzN, StorniT et al.: Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol.172(9) , 5598–5605 (2004).
  • Zebedee SL , LambRA: Growth restriction of Influenza A virus by M2 protein antibody is genetically linked to the M1 protein.Proc. Natl Acad. Sci. USA86(3) , 1061–1065 (1989).
  • Zharikova D , MozdzanowskaK, FengJ et al.: Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. J. Virol.79(11) , 6644–6654 (2005).
  • Nishimura K , KimS, ZhangL et al.: The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR. Biochemistry41(44) , 13170–13177 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.